Wang et al. (2022) discovered that DCA, when metabolized by Clostridium-specific metabolites, facilitates the transition of HER2-positive breast cancer cells from the G0/G1 phase into the S-phase, thereby inhibiting cell proliferation and hindering breast cancer progression. The gene discussed is ERBB2; the disease is breast carcinoma.